ArticleJournal of virology2026
The m
Yi Liang, Chenxin Tan, Xinyu Chang, Chenyang Lyu, Dongmei Liu, Shuwen Xu, Dian Zhu, Benquan Liu, Xiaoyi Yuan, Xiaorui Zuo and 2 more
Abstract read
In one paragraphArticle in Journal of virology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
12 authors.
Yi Liang *State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, China.ORCID 0009-0004-5018-8432 Chenxin Tan *State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, China.
Xinyu ChangState Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, China.
Chenyang LyuState Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, China.
Dongmei LiuState Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, China.
Shuwen XuState Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, China.
Dian ZhuState Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, China.
Benquan LiuDepartment of Pharmacy, Nantong Tumor Hospital, Affiliated Tumor Hospital of Nantong University, Nantong, China.
Xiaoyi YuanState Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, China.
Xiaorui ZuoState Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, China.
Xiao-Min LiuSchool of Life Science and Technology, China Pharmaceutical University, Nanjing, China.
Guangyong MaState Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, China.ORCID 0000-0002-2003-7201 Funding
Fundamental Research Funds for the Central Universities 2632026PY10National Natural Science Foundation of China 32270171Natural Science Foundation of Hangzhou 2025SZRJJ1409
6 · The paper itselfAbstract
Indexed as
AdenosineGene Products, taxHTLV-I InfectionsHuman T-lymphotropic virus 1RNA-Binding ProteinsRNA, ViralHEK293 CellsHumansRNA MethylationRNA StabilityVirus ReplicationAdenosineGene Products, taxN-methyladenosineRNA-Binding ProteinsRNA, Viraltax protein, Human T-lymphotrophic virus 1YTHDF2 protein, humanHTLV-1m6ATaxYTHDF2
Identifiers
PMID42138387
PMCPMC13288785
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390